Clinical Documents

To edit the draft, click on the text box below.

×

Draft a comprehensive differential diagnosis for acute substernal chest pain in a 45-year-old male with hypertension and hyperlipidemia, diaphoresis, exertional onset, and normal initial ECG/troponin; include life-threatening causes first, key distinguishing features, and immediate diagnostic next steps.

Draft a detailed differential diagnosis for new-onset unilateral throbbing headache with visual aura and brief monocular vision loss in a 32-year-old female on oral contraceptives; include red-flag symptoms, stroke/TIA considerations, and recommended initial workup.

Draft an assessment and plan for stage-2 hypertension (BP 162/98) in an obese 52-year-old with suspected obstructive sleep apnea; include ASCVD risk estimate, lifestyle prescriptions, first-line pharmacotherapy with drug/dose/targets, baseline labs/monitoring, and 4–6 week follow-up.

Draft an assessment and plan for type 2 diabetes follow-up with A1c 9.2% on metformin 1,000 mg BID and eGFR 65; compare adding a GLP-1 receptor agonist vs an SGLT2 inhibitor, address weight loss goals, hypoglycemia education, vaccinations, and micro/macrovascular screening.

Draft a history and physical for a patient presenting with chest pain, including HPI using OLDCARTS, pertinent ROS, PMH/meds/allergies, FH/SH, focused cardiac/pulmonary exam, initial labs and imaging orders, prioritized differential, HEART score risk stratification, and early management.

Draft a history and physical for a new patient with progressive exertional dyspnea, orthopnea, and bilateral leg edema; include differential (heart failure, COPD, PE, anemia, renal disease), targeted exam maneuvers, and first-line diagnostics and management.

Draft a progress note for COPD follow-up two weeks after an acute exacerbation treated with prednisone and antibiotics; include symptom trajectory, CAT score (if available), inhaler technique/adherence, oxygen needs, spirometry plan, smoking cessation counseling, and return precautions.

Draft a progress note for post-operative day 2 after total knee arthroplasty; include pain control strategy, DVT prophylaxis, PT/OT milestones, wound status, bowel/urinary function, labs/vitals review, complications screening, and discharge readiness.

Draft a discharge summary for community-acquired pneumonia admission; include admission/discharge dates, presenting symptoms, radiology/labs, pathogen if identified, inpatient therapies and response, discharge medications with durations, pending tests, follow-up appointments, and return precautions.

Draft a discharge summary for myocardial infarction managed with PCI and drug-eluting stent placement; include cath findings, complications, inpatient course, discharge medications (DAPT, statin, beta-blocker, ACEi/ARB), cardiac rehab referral, and follow-up plan.

Draft discharge instructions for a patient hospitalized with acute decompensated heart failure; include daily weights, sodium and fluid restriction amounts, medication list with dosing, signs of worsening heart failure, follow-up appointments, and lab monitoring plan.

Draft discharge instructions for an asthma exacerbation; include controller and reliever regimen, steroid taper schedule, spacer technique, trigger avoidance, a written asthma action plan, return precautions, and follow-up timing.

Draft a patient handout on managing high blood pressure in plain language; explain what BP numbers mean, key lifestyle steps (DASH diet, sodium limits, alcohol moderation), home BP monitoring instructions, medication adherence tips, and when to call the doctor.

Draft a patient handout for type 2 diabetes education in plain language; cover A1c goals, the plate method, physical activity targets, self-monitoring of blood glucose, hypoglycemia signs and the 15-15 rule, foot care basics, and a vaccination checklist.

Draft a summary of the latest CDC and WHO guidelines for managing community-acquired pneumonia in adults, including empiric antibiotic choices, duration of therapy, and follow-up recommendations.

Draft a plain-language overview of the ADA and AACE guidelines for diabetes management, focusing on A1c goals, weight management, and the use of GLP-1 receptor agonists and SGLT2 inhibitors.

Draft a summary of the 2024 USPSTF breast cancer screening recommendations, including updated screening intervals, risk-based approaches, and the role of MRI for high-risk patients.

Draft a concise summary of NCCN guidelines for melanoma management, including staging, surgical margins, adjuvant therapy, and checkpoint inhibitor recommendations.

Draft treatment alternatives for community-acquired MRSA skin infections in patients allergic to sulfa drugs; include oral and IV options, dosing, and duration.

Draft treatment alternatives for patients with type 2 diabetes who are unable to tolerate GLP-1 receptor agonists due to nausea; include medication substitutions and lifestyle recommendations.

Draft a summary of options for treating refractory depression, comparing ketamine infusions, transcranial magnetic stimulation (TMS), and electroconvulsive therapy (ECT).

Draft treatment options for advanced prostate cancer, including hormonal therapy, radiopharmaceuticals, and novel androgen receptor pathway inhibitors.

Draft a summary of recent research on mRNA vaccine technology beyond COVID-19, including applications in oncology and autoimmune disease prevention.

Draft an easy-to-understand overview of long COVID research, summarizing major symptoms, hypothesized mechanisms, and emerging treatment approaches.

Draft a summary of current research on Alzheimer’s disease biomarkers, including amyloid and tau imaging, and discuss how they influence diagnosis and trial design.

Draft an explanation of the interaction between warfarin and antibiotics such as ciprofloxacin or TMP-SMX, including INR effects and management recommendations.

Draft a summary evaluating drug interactions for patients taking Paxlovid and common cardiovascular drugs; include mechanism and recommended dose adjustments.

Draft a summary of the common and serious side effects of semaglutide, including GI intolerance, gallbladder disease, and thyroid-related warnings.

Draft an overview of potential side effects associated with long-term corticosteroid use, including osteoporosis, glucose intolerance, and adrenal suppression.

Draft a summary of essential lab tests to order in suspected acute pancreatitis, including amylase, lipase, liver enzymes, and metabolic panels, with interpretation guidance.

Draft laboratory workup recommendations for suspected hypothyroidism, including TSH, free T4, thyroid antibodies, and when to consider secondary causes.

Draft an explanation of which labs should be monitored in patients receiving methotrexate therapy, including CBC, LFTs, renal function, and frequency of monitoring.

why choose us

Edit Geo

×

300×250 Ad Slot

Research Article: IFSMT-based supervised nursing combined with moderate-intensity exercise training for pulmonary rehabilitation in stable COPD: a randomized controlled trial

Date Published: 2026-07-01

Abstract:
To investigate the effects of supervised nursing combined with moderate-intensity exercise training based on the Individual and Family Self-Management Theory (IFSMT) on pulmonary rehabilitation in patients with stable chronic obstructive pulmonary disease (COPD), and to provide evidence for improving self-management ability, pulmonary function, and quality of life. Using a convenience sampling method, 112 patients with stable COPD admitted to a hospital in Zhejiang Province, China, were enrolled and randomly assigned to a control group or an intervention group using a random number table, with 56 patients in each group. The control group received routine nursing care for stable COPD, including disease education, medication guidance, and general rehabilitation advice. The intervention group received a comprehensive intervention consisting of supervised nursing combined with moderate-intensity exercise training based on the IFSMT framework. The intervention was implemented across three dimensions—context, process, and outcomes—focusing on enhancement of knowledge and health beliefs and family support integration (context), self-regulation guidance, individualized rehabilitation plan development, moderate-intensity exercise training, and continuous assessment and follow-up (process), as well as social facilitation and dynamic adjustment of the intervention program (outcomes). Before and after the intervention, the Chinese version of the Partners in Health scale (PIH), the Chinese-modified Fatigue Impact Scale (FIS), Borg dyspnea scale, and the 6-min walk distance (6MWD) were used to quantitatively assess and compare self-management ability, fatigue severity, pulmonary function, and exercise capacity between the two groups. After systematic data collection, data management, and statistical analysis, the results showed that post-intervention forced expiratory volume in one second (FEV 1 ) was higher in the intervention group than in the control group [1.05 (0.87, 1.40) vs. 0.89 (0.66, 1.17), Z?=??2.91, p =?0.004]. Forced vital capacity (FVC) after the intervention was also significantly higher in the intervention group than in the control group (2.50?±?0.63 vs. 1.91?±?0.61, t?=??5.06, p <?0.001). In terms of exercise capacity, the 6-min walk distance (6MWD) was significantly greater in the intervention group than in the control group (306.37?±?91.98?m vs. 257.95?±?92.08?m, t?=??2.78, p =?0.006). Peak expiratory flow (PEF) after the intervention was also higher in the intervention group [4.31 (3.73, 5.99) vs. 2.24 (1.88, 2.92), Z?=??7.63, p <?0.001]. Regarding symptom-related outcomes, Borg dyspnea scores were lower in the intervention group than in the control group [2.00 (1.00, 3.25) vs. 4.50 (3.00, 6.00), Z?=??6.18, p <?0.001]. COPD Assessment Test (CAT) scores were also significantly lower in the intervention group [12.00 (10.00, 15.00) vs. 20.50 (16.75, 25.00), Z?=??7.63, p <?0.001]. For fatigue and self-management outcomes, Fatigue Impact Scale (FIS) scores were significantly lower in the intervention group than in the control group [23.00 (20.00, 28.25) vs. 42.50 (32.25, 56.25), Z?=??7.04, p <?0.001]. Similarly, Partners in Health (PIH) scores were lower in the intervention group [29.00 (22.00, 34.00) vs. 37.00 (28.00, 44.50), Z?=??3.50, p <?0.001], indicating better self-management ability. In addition, Activities of Daily Living (ADL) scores were significantly lower in the intervention group than in the control group [23.00 (19.75, 25.25) vs. 32.50 (28.00, 38.00), Z?=??7.87, p <?0.001], suggesting better functional status. Regarding modified Medical Research Council (mMRC) dyspnea grades after the intervention, in the intervention group, 5.36% (3/56) of patients were classified as grade 0, 57.14% (32/56) as grade 1, 32.14% (18/56) as grade 2, 1.79% (1/56) as grade 3, and 3.57% (2/56) as grade 4. In the control group, 1.79% (1/56) were classified as grade 0, 1.79% (1/56) as grade 1, 53.57% (30/56) as grade 2, 42.86% (24/56) as grade 3, and 0.00% (0/56) as grade 4. Overall, dyspnea severity was significantly lower in the intervention group than in the control group, and the between-group difference was statistically significant ( p <?0.001). The comprehensive intervention integrating supervised nursing and moderate-intensity exercise training based on the Individual and Family Self-Management Theory (IFSMT) may improve self-management ability, reduce disease-related fatigue, enhance pulmonary function and activities of daily living, and improve quality of life in patients with stable COPD. These findings may provide a reference for pulmonary rehabilitation management in this population.

Introduction:
With the accelerating global population aging process and the combined effects of environmental factors, chronic respiratory diseases have become a major public health threat to human health. Among them, chronic obstructive pulmonary disease (COPD), characterized by a “triple-high” burden of high prevalence, high disability rate, and high mortality, has become the third leading cause of death worldwide, following ischemic heart disease and stroke ( 1 ). Epidemiological data indicate that approximately 545 million…

Read more

300×250 Ad Slot

×
Chat & Ask Questions Career Openings Medical Doctors Check on Drug
Interactions Latest Health News
by WebHealthNetwork Get CME Credits Latest Clinical Trials Latest Research Articles Clinical Documents Update Profile

News

Chat

HCP Tools

Careers

Update Profile